The presence of the co-inhibitory molecule B7 homolog 4 (B7-H4) in cancer cells may contribute to tumor progression by inhibiting T-cell proliferation and cytokine production within the tumor microenvironment [96,97]. The gene discussed is VTCN1; the disease is neoplasm.